Medical diet and Scandishake


Medical Diet Symptoms and Causes

Food provides the energy and nutrients you need to be healthy. If you don't get enough nutrients -- including proteins, carbohydrates, fats, vitamins, and minerals - you may suffer from malnutrition.

Causes of malnutrition include:

  • Lack of specific nutrients in your diet. Even the lack of one vitamin can lead to malnutrition.
  • An unbalanced diet
  • Certain medical problems, such as malabsorption syndromes and cancers

Symptoms may include fatigue, dizziness, and weight loss. Or, you may have no symptoms. To diagnose the cause of the problem, your doctor may do blood tests and a nutritional assessment. Treatment may include replacing the missing nutrients and treating the underlying cause.

Check out the latest treatments for medical diet

medical diet treatment research studies

Scandishake clinical trials, surveys and public health registries

Find Drug Side Effect reports

Scandishake Side Effects

Cardiac Disorder (4)
Cerebral Atrophy (4)
Dysphagia (3)
Multiple System Atrophy (2)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

Arthritis Treatment Safe, Natural Cure for Adults. Synflex Liquid Glucosamine, Rheumatoid Arthritis Joint Pain Relief Remedy, Diet Supplements. Synflex, Glucosamine for Dogs. Free Shipping! <a href=''&g

Have been taking Kliovance for approx 5 years. I am aged 55 years and have been diagnosed with hypertension. I have a sedentary lifestyle, a poor diet, and a stressful job. I have been getting a difference of opinion between 2 doctors. One says th

I have just come back from a funeral for my brother. He was just 62. He was on statin medicine but his cholestrol, blood pressure, weight and diet was very much in control. In fact just a day before his death the doctor told him that he was doing f


Have been taking Kliovance for approx 5 years. I am aged 55 years and have been diagnosed with hypertension. I have a sedentary lifestyle, a poor diet, and a stressful job. I have been getting a difference of opinion between 2 doctors. One says that

I am BiomedicalINGINEER in Abidjan IVORY COST (WEST AFRICA) My device is HFQ-8000P SERIAL NO 564 <strong>TREX MEDICAL SYSTEMS CORP</strong>and i have an error&nbs

<span style='color: #808080;'><b>i was given a flu shot on 11/18/10 the medical asst did the injection higher than i have ever had in the past. she injected right on the bone. the pain i have is horrible. i had an exray. (no foreign body)

...this drug should not be prescribed for use out of medical insttitutions and 24/7 MD watch

42 y.o. female, no medical hx. of urinary incontinence until the use of Mucinex D 1200mg po bid. Resolved after med. being discontinued.

66 yearr old male living in Winnipeg, MB Cannada. Ialso have other medical problems besides this one. Like Epilepsy, Antidepressant,Migraines,Chloresterol,Klinefelter's Syndrome,High blood pressure, Shortness of breath, HIV, ITCHING.

Medical Diet Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy
Outcome Measures: Gestational diabetes mellitus;   insulin resistance
2 Recruiting REAL HEALTH-Diabetes: Reach Ahead for Lifestyle and Health-Diabetes
Conditions: Type 2 Diabetes Mellitus;   Obesity
Interventions: Behavioral: In Person Group (IP);   Behavioral: Telephone Conference Call Group (TCC);   Behavioral: Medical Nutrition Therapy (MNT)
Outcome Measures: Weight Loss;   Medical Outcomes;   Psychological Outcomes-low fat diet self-efficacy;   Psychological Outcomes-exercise self-efficacy;   Behavioral Outcomes-low fat diet eating behavior;   Behavioral Outcomes-dietary restraint;   Behavioral Outcomes-activity;   Psychological Outcomes-quality of life;   Psychological Outcomes-diabetes-specific quality-of-life;   Psychological Outcomes-depression
3 Recruiting Diabetes in India Nutrition Guidelines Study (DINGS)
Condition: Type 2 Diabetes Mellitus
Interventions: Other: MNT according to AND EBNPG for Type 2 DM;   Other: Usual Nutrition Care
Outcome Measures: HbAIc decrease;   Weight change
4 Recruiting Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions
Condition: Health Behavior
Intervention: Other: Food-based intervention; increased fruits and vegetables
Outcome Measures: Skin Carotenoid Scores (SCS);   Body weight
5 Recruiting Regulation of FGF21 by Nutritional Challenges
Conditions: Fasting;   Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: Behavioral: Fasting;   Behavioral: Diet;   Dietary Supplement: oral carbohydrate challenge
Outcome Measures: Fibroblast Growth Factor 21 levels in serum and fat;   Polymerase 1 and Transcript Release Factor levels in fat;   Urine and serum ketosis;   Hepatic fat content;   change in serum triglyceride levels;   change in glucose and insulin levels
6 Unknown  Validation of a STAMP in Hospitalized Children and the Effect of Its Use on the Awareness of the Medical Staff
Condition: Malnutrition
Interventions: Other: questionnaire STAMP and dietary;   Other: No intervention
Outcome Measures: Validity and reliability;   Validity and efficiency
7 Not yet recruiting Glycosade v UCCS in the Dietary Management of Hepatic GSD
Condition: Glycogen Storage Disease
Intervention: Dietary Supplement: Medical Food - Glycosade
Outcome Measures: To assess if Glycosade® will result in improved blood glucose, lactate and ketone levels in a larger group of patients with GSD I, III, VI & IX as measured by duration of normal blood glucose levels or prevention of ketosis;   1. The insulin area under the curve during dietary management with UCCS compared to dietary management with Glycosade®.;   2. The area under the curve in lactate, BOHB, during dietary management with UCCS compared to dietary management with Glycosade®.
8 Recruiting Evaluation of Diet and Exercise in Prostate Cancer Patients
Condition: Prostate Cancer
Outcome Measures: Changes in the patient quality of life (QoL) using the Medical Outcomes Study Short Form - 36 (SF-36);   Changes in the University of California Los Angeles Prostate Cancer Index (UCLA-PI);   Changes in the sexual function using the International Index of Erectile Function (IIEF-5);   Changes in the proportion of patients with castrate levels of testosterone and normal levels of Prostatic Specific Antigen (PSA) at 36 months of treatments.;   Number of patients with Adverse Events;   Changes in the patient's medical condition;   Changes in the Doctor-Patient communication
9 Recruiting Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Behavioral: Diet and water adjustment
Outcome Measures: Mean serum copeptin (a reflection of endogenous vasopressin production) at week 2;   Total daily urinary solutes;   Mean serum copeptin level at week one
10 Not yet recruiting Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease
Condition: Parkinson Disease
Intervention: Dietary Supplement: different diets
Outcome Measures: quality of life;   dyskinesias;   fluctuations;   motor function
11 Unknown  An Elimination Diet Using a New Amino Acid Based Formula: Immunological and Clinical Effects in Cow's Milk Allergy
Conditions: Allergy;   Food Allergy
Intervention: Other: Special Medical Food
Outcome Measures: To evaluate the development of oral tolerance in infants with IgE mediated CMA on control or test AAF.;   To evaluate maturation of the GI immune system in IgE mediated CMA To confirm that the test formula is effective in the dietary management of CMA To assess frequency of other allergies
12 Recruiting Canadian Health Advanced By Nutrition and Graded Exercise
Condition: Metabolic Syndrome
Interventions: Behavioral: Dietary Intervention;   Behavioral: Exercise Prescription and Fitness Program
Outcome Measures: The proportion of patients that have a reversal of the features of the metabolic syndrome present in individual patients (return to the normal range) or elimination of drug therapy based on normalization of the features of the metabolic syndrome;   The decreased medical need for pharmacotherapy for metabolic syndrome since baseline;   Each individual's compliance to diet and exercise interventions
13 Recruiting Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk
Condition: Malnutrition
Outcome Measures: Infectious complication;   cost effectiveness
14 Unknown  A Sustainable Diet for Hadassah Employees Workers
Conditions: Obesity;   Physical Activity
Intervention: Behavioral: Nutritional and Activity Promotion
Outcome Measures: Change in amount of fruit/vegetable consumption per day;   Amount of physical activity per week
15 Not yet recruiting Effectiveness of a Mobile Application as an Adjunct to Medical Advice to Promote Healthy Habits
Conditions: Overweight;   Obesity
Interventions: Behavioral: APP + health advice;   Behavioral: health advice
Outcome Measures: weight reduction;   BMI;   blood pressure;   heart rate;   smoking cessation;   waist circumference;   plasma cholesterol;   satisfaction;   index of physical exercise
16 Recruiting Taste, Smell and Chemotherapy (TASTY)
Condition: Testicular Cancer
Interventions: Procedure: Dexa scan;   Procedure: audiogram;   Procedure: measurement of heart rate variability and baroreflex sensitivity;   Procedure: Glucose tolerance assessment;   Dietary Supplement: oral nutrition supplements;   Behavioral: Two day food records;   Behavioral: Food Frequency Questionnaire
Outcome Measures: investigate the nature, prevalence, and duration of taste and smell changes;   explore the short- and long-term consequences of taste and smell changes;   investigate the appreciation of medical food products;   Are changes related to metabolic syndrome?;   Is chemotherapy induced neurotoxicity related to changes?
17 Unknown  Celiac Disease School for Women Living on a Gluten-free Diet
Conditions: Education of Patients;   Counseling;   Problem-Based Learning
Interventions: Behavioral: Celiac school;   Behavioral: Usual care of celiac disease women
Outcome Measures: Subjective health and well-being;   Gastrointestinal symptoms and Psychological well-being
18 Not yet recruiting Pilot Study of Partial Enteral Nutrition With a Unique Diet for the Treatment of Adults Patients With Crohn's Disease
Condition: Crohn's Disease
Interventions: Dietary Supplement: Crohns Disease Exclusion Diet + PEN;   Other: Crohns Disease Exclusion Diet
Outcome Measures: Clinical remission defined as HBI<4 .;   Steroid free remission;   Mucosal healing- Normal colonoscopy of normal MRE with normal calprotectin;   Changes in mean CRP;   Change in mean fecal calprotectin;   Change in mean and ESR
19 Recruiting MAIN STUDY: Low Glycaemic Index (GI) Diet in the Management of GDM SUB-STUDY: The Breast Milk Sub-Study
Condition: Gestational Diabetes Mellitus
Interventions: Other: Standard Care;   Other: Low GI diet
Outcome Measures: MAIN STUDY: Percentage of postprandial self monitored blood glucose (SMBG) values within the target range;   SUB-STUDY (n=75): Oxygen Radical Absorbance Capacity (ORAC) (Antioxidant Capacity) of transitional and mature breast milk.;   MAIN STUDY: Infant birth weight;   MAIN STUDY: Percentage of self-monitored fasting glucose values within the target range;   MAIN STUDY: Glucose variability;   MAIN STUDY: Insulin prescription incidence;   MAIN STUDY: Mean fasting glucose;   MAIN STUDY: Mean postprandial glucose;   MAIN STUDY: Mean post-breakfast glucose;   MAIN STUDY: Mean post-lunch blood glucose;   MAIN STUDY: Mean post-dinner blood glucose;   MAIN STUDY: Change in LDL oxidation at 4 weeks;   MAIN STUDY: LDL oxidation 6-8 weeks after delivery;   MAIN STUDY: Change in Oxygen Radical Absorbance Capacity (ORAC) of plasma at 4 weeks;   MAIN STUDY: Change in c-reactive protein (CRP) at 4 weeks;   MAIN STUDY: Post-partum CRP;   MAIN STUDY: Post-partum fasting serum glucose;   MAIN STUDY: Post-partum serum glucose concentration 2 hours after consumption of 75g oral glucose (2hrPC serum glucose).;   MAIN STUDY: Incidence of post-partum impaired glucose tolerance;   MAIN STUDY: Incidence of post-partum diabetes mellitus;   MAIN STUDY: Maternal weight gain;   MAIN STUDY: Rate of maternal weight gain;   MAIN STUDY: Change in infant weight;   MAIN STUDY & SUB-STUDY (n=75): Maternal dietary intake;   SUB-STUDY (n=75): Concentration of vitamin C, E, and Beta-carotene in transitional breast milk;   SUB-STUDY (n=75): Concentration of vitamin C, E, and Beta-carotene in mature breast milk;   MAIN STUDY: Infant demographics;   MAIN STUDY: Change in infant body measurements from birth to 6-8 weeks post-partum;   MAIN STUDY: Infant APGAR score at delivery;   MAIN STUDY: Change in maternal blood pressure and resting pulse from randomization to 4 weeks;   MAIN STUDY: Maternal blood pressure and resting pulse at 6-8 weeks post-partum;   MAIN STUDY: Infant waist circumference at 6-8 weeks;   MAIN STUDY: Change in ultrasound measurements from randomization to delivery.;   MAIN STUDY: Maternal height at baseline;   MAIN STUDY: Maternal medical history;   MAIN STUDY: Maternal medical complications from baseline to 6-8 weeks post-partum;   MAIN STUDY: Change in maternal weight from delivery at 6-8 weeks post-partum;   MAIN STUDY: Maternal pre-natal demographic information;   MAIN STUDY: Maternal post-partum socio-demographic data related to infant feeding practices;   MAIN STUDY: Length of time between delivery and maternal breast fullness;   MAIN STUDY: Change in conjugated dienes at 4 weeks;   MAIN STUDY: Conjugated dienes post-partum;   MAIN STUDY: Oxygen Radical Absorbance Capacity (ORAC) of venous plasma post-partum;   MAIN STUDY: Change in full lipid profile at 4 weeks;   MAIN STUDY: Full lipid profile post-partum;   MAIN STUDY: Change in incidence and severity of symptoms from baseline to 6-8 weeks postpartum;   MAIN STUDY: Infant feeding practices;   MAIN STUDY: Participant satisfaction of baseline education class;   MAIN STUDY: Change in participant knowledge of GI from baseline to 6-8 weeks after delivery;   MAIN STUDY: Participant knowledge of GI at baseline;   MAIN STUDY: Change in participant opinion on availability and acceptability of study diet foods;   MAIN STUDY: Difference in dietary GI between study groups.;   MAIN STUDY: Change in behaviour from baseline (pre-class) to 6-8 weeks after delivery.
20 Unknown  Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
Condition: Chronic Kidney Disease
Interventions: Other: Diet counseling;   Drug: Phosphorus binder
Outcome Measures: Designated safety measure; serum calcium;   Designated safety measure:  phosphorus;   Changes in flow;   Other Changes